Link to this page
Ontology of Drug Neuropathy Adverse Events
| Preferred Name | Bromocriptine | |
| Synonyms |
InChIKey=OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione bromoergocriptine (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman C32H40BrN5O5 2-bromo-alpha-ergokryptine bromocriptinum (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman [H][C@@]12Cc3c(Br)[nH]c4cccc(C1=C[C@H](CN2C)C(=O)N[C@@]1(O[C@]2(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@@]25[H])C1=O)C(C)C)c34 2-bromo-alpha-ergokryptin 2-bromo-alpha-ergocryptine bromocryptine InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1 Bromocriptine (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman |
|
| Definitions |
An indole alkaloid that has formula C32H40BrN5O5. |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_3181 |
|
| database_cross_reference |
Patent:DE1926045 DrugBank:DB01200 KEGG COMPOUND:25614-03-3 KEGG COMPOUND:C06856 Wikipedia:Bromocriptine Beilstein:741357 Patent:US3752814 KEGG DRUG:D03165 ChemIDplus:25614-03-3
|
|
| definition |
An indole alkaloid that has formula C32H40BrN5O5.
|
|
| has_exact_synonym |
Bromocriptine (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
|
|
| has_related_synonym |
InChIKey=OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione bromoergocriptine (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman C32H40BrN5O5 2-bromo-alpha-ergokryptine bromocriptinum (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman [H][C@@]12Cc3c(Br)[nH]c4cccc(C1=C[C@H](CN2C)C(=O)N[C@@]1(O[C@]2(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@@]25[H])C1=O)C(C)C)c34 2-bromo-alpha-ergokryptin 2-bromo-alpha-ergocryptine bromocryptine InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1
|
|
| has_RxCUI |
1760
|
|
| id |
CHEBI:3181
|
|
| imported from | ||
| label |
bromocriptine Bromocriptine
|
|
| notation |
CHEBI:3181
|
|
| prefLabel |
Bromocriptine
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |